Literature DB >> 26183284

Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment.

M S Dikopf1, K H Patel1, V J Setlur1, J I Lim1.   

Abstract

PURPOSE: To evaluate the outcomes and complications of 25-gauge (G) pars plana vitrectomy (PPV) for repair of diabetic tractional retinal detachment (TRD).
METHODS: Retrospective review of consecutive, single-surgeon 25-G PPV cases between July 2007 and July 2014. Seventy eyes from 55 patients were operated on for diabetic TRD; all eyes were tamponaded with sulfur hexafluoride, octofluoropropane, silicone oil, or balanced salt solution. Mean age at surgery was 47.7 years (range 23-76 years), and mean length of follow-up was 713 days (range 90-2368 days; median 671 days). Primary outcomes included best-corrected visual acuity (BCVA), intraocular pressure (IOP), anatomic success, redetachment, and endophthalmitis.
RESULTS: Preoperatively, 49 eyes (70%) had a concurrent rhegmatogenous component (8 of which also had proliferative vitreoretinopathy (PVR)). Mean BCVA improved from logarithm of the minimal angle of resolution 1.59 (20/800, SD 0.88) to 0.68 postoperatively (20/100, 0.77), P-value<0.001. Mean IOP increased from 15.9 to 20 mm Hg 1 day after surgery. Elevated postoperative IOP (≥ 22 mm Hg) occurred in 25 eyes, and low IOP (≤ 5 mm Hg) occurred in 2 eyes. Primary reattachment was achieved in 63 eyes (90%), and final anatomical success occurred in 69 eyes (99%). There were no cases of endophthalmitis.
CONCLUSIONS: Twenty-five-G PPV repair was safe and effective in the repair of diabetic TRD, including eyes with a combined rhegmatogenous detachment or PVR. Gas, silicone oil, and balanced salt solution tamponading agents all proved to be efficacious in this surgical population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183284      PMCID: PMC4565947          DOI: 10.1038/eye.2015.126

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  29 in total

1.  Alterations in the corneal topography after pars plana vitrectomy with the standard system of 20-gauge and the 25-gauge transconjunctival sutureless vitrectomy.

Authors:  Alcio Coutinho de Paula; João Jorge Nassaralla Júnior; Francisco Weliton Rodrigues; Rodrigo Egídio da Silva; Rodrigo Salustiano Correa e Silva; David Roberto Barbosa Junior
Journal:  Semin Ophthalmol       Date:  2012 Jan-Mar       Impact factor: 1.975

2.  Postoperative complications associated with 25-gauge pars plana vitrectomy.

Authors:  Omesh P I Gupta; Eric D Weichel; Carl D Regillo; Mitchell S Fineman; Richard S Kaiser; Allen C Ho; J Arch McNamara; James E Vander
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Jul-Aug

Review 3.  25-Gauge transconjunctival sutureless vitrectomy.

Authors:  Eric Chen
Journal:  Curr Opin Ophthalmol       Date:  2007-05       Impact factor: 3.761

4.  Incidence of endophthalmitis following 20-gauge and 25-gauge vitrectomy.

Authors:  John O Mason; Jacob J Yunker; Rachel S Vail; Milton F White; Richard M Feist; Martin L Thomley; Michael A Albert; Tarek O Persaud
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

Review 5.  Advantages and limitations of small gauge vitrectomy.

Authors:  John T Thompson
Journal:  Surv Ophthalmol       Date:  2011-01-14       Impact factor: 6.048

6.  Intraoperative retinal break formation in 23-/25-gauge vitrectomy versus 20-gauge vitrectomy.

Authors:  Irmingard M Neuhann; Ralf-Dieter Hilgers; Karl-Ulrich Bartz-Schmidt
Journal:  Ophthalmologica       Date:  2012-11-20       Impact factor: 3.250

7.  Vitrectomy for diabetic traction retinal detachment involving the macula.

Authors:  T A Rice; R G Michels; E F Rice
Journal:  Am J Ophthalmol       Date:  1983-01       Impact factor: 5.258

8.  Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.

Authors:  Michael S Ibarra; Martin Hermel; Jonathan L Prenner; Tarek S Hassan
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

9.  Faster visual recovery after 23-gauge vitrectomy compared with 20-gauge vitrectomy.

Authors:  Raja Narayanan; Anshuman Sinha; Rajeev K Reddy; Sannapaneni Krishnaiah; Baruch D Kuppermann
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

10.  Comparative evaluation of 23- and 25-gauge microincision vitrectomy surgery in management of diabetic macular traction retinal detachment.

Authors:  Atul Kumar; Kavita Duraipandi; Varun Gogia; Sri Vatsa Sehra; Shikha Gupta; Neha Midha
Journal:  Eur J Ophthalmol       Date:  2013-05-15       Impact factor: 2.597

View more
  6 in total

1.  Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.

Authors:  Mikel Mikhail; Andre Ali-Ridha; Sarah Chorfi; Michael A Kapusta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-02       Impact factor: 3.117

2.  Treatment History as a Predictor for Change in Visual Acuity After Surgical Correction of Diabetic Retinal Traction Detachment.

Authors:  Zachary Unruh; Elizabeth Ablah; Hyarettin Okut; David M Chacko
Journal:  Kans J Med       Date:  2022-04-29

3.  Outcomes of 25-gauge vitrectomy with relaxing retinectomy for retinal detachment secondary to proliferative vitreoretinopathy.

Authors:  Yi Jiang; Daniel J Oh; Wyatt Messenger; Jennifer I Lim
Journal:  J Vitreoretin Dis       Date:  2019-02-26

4.  Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.

Authors:  Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

5.  Comparison of Retinal Changes Following Silicone Oil and Perfluoropropane Gas Tamponade for Proliferative Diabetic Retinopathy Patients.

Authors:  Tan Wang; Erqian Wang; Huan Chen; Ningning Li; Hanyi Min
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

6.  Hybrid 23/27 Gauge Vitrectomy - Combining the Charm of 27G with the Efficacy of 23G.

Authors:  Justus G Garweg; Dean Ouassi; Isabel B Pfister
Journal:  Clin Ophthalmol       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.